DENTSPLY SIRONA Inc.

XRAYNASDAQHealthcare● Active

$10.26

+$0.26(+2.60%)

Market Cap$2.1B

P/E Ratio—

52W High$17.09

52W Low$9.41

Avg Volume4.7M

Open$10.01

Beta0.91

Free Cash Flow Financials Revenue

DENTSPLY SIRONA Inc. (XRAY) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

XRAY · free cash flow · updated Jun 9, 2026

Core FCF metrics

XRAY · FCF · TTM · margin & CAGR

Free cash flow was $104.0M for FY2025 (fiscal year ending 2025-12-31), down 63.0% year-over-year The FCF margin was 2.8%. Five-year CAGR stands at -28.6%.

FY2025 Free Cash Flow$104.0M▼ -63.0% YoY

Trailing 12M (TTM)$104.0Mtrailing 4 quarters sum

FCF Margin2.8%$104.0M ÷ revenue

3-Year CAGR-34.4%FY2022 → FY2025

5-Year CAGR-28.6%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

XRAY · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$235.0M(131M)$104.0M▼ 63.0%2.8%

FY2024$461.0M(180M)$281.0M▲ +23.2%7.4%

FY2023$377.0M(149M)$228.0M▼ 38.0%5.8%

FY2022$517.0M(149M)$368.0M▼ 28.5%9.4%

FY2021$657.0M(142M)$515.0M▼ 8.4%12.2%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

XRAY · P/FCF · FCF yield · FCF per share

DENTSPLY SIRONA Inc. (XRAY) trades at a FCF yield of 5.06% and a price-to-free-cash-flow ratio of 19.7x. FCF per share stands at $0.52, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

5.06%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.52

TTM FCF ÷ Shares Outstanding

Price / FCF

x19.7

Share Price ÷ FCF per Share

EV / FCF (TTM)

x40.4

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

XRAY · cash flow statement · operating / investing / financing

For FY2025, DENTSPLY SIRONA Inc. generated $235.0M in operating cash flow and spent 131M in capital expenditures, yielding $104.0M in free cash flow.

Operating Activities

+$235.0M

Cash from core business operations

2025-12-31

Investing Activities

−$132.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$80.0M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($235.0M) − |CapEx| (131M) = FCF ($104.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

XRAY vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

DENTSPLY SIRONA Inc.YOU

XRAY

$104.0M-63.0%2.8%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

DENTSPLY SIRONA Inc. (XRAY) reported free cash flow of $104.0M for FY2025 (fiscal year ending 2025-12-31), down 63.0% year-over-year. The FCF margin was 2.8%.

Based on available data, DENTSPLY SIRONA Inc. has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $562.0M in FY2020. The 5-year CAGR stands at -28.6%.

DENTSPLY SIRONA Inc.'s FCF yield is 5.06% and price-to-FCF ratio is 19.7x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

XRAY free cash flow · 8 questions

DENTSPLY SIRONA Inc. free cash flow was $104.0M for FY2025, down 63.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $104.0M.

XRAY free cash flowXRAY FCFXRAY FCF 2025XRAY free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · DENTSPLY SIRONA Inc. · DENTSPLY SIRONA Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026